A Reassessment is Possible for Mirum Pharmaceuticals in 2026 — Stock Breaks Out to All-Time High!
Reading Time: 1 minute
I first presented Mirum Pharmaceuticals in 2023 at the Tenbagger forum at a price of 28 USD. Since then, the stock has performed wonderfully and is now trading at an all-time high of 80 USD. The company focuses on the development and marketing of therapies for chronic liver diseases. The company impresses with strong revenue growth, driven mainly by Livmarli, which recently grew by 56% year-over-year. It is the only medication in the USA approved for the treatment of cholestatic itching in patients with Alagille syndrome (ALGS) aged three months...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
